POSSIBLE CYTOSTATIC ACTION OF TETRACYCLINES IN THE TREATMENT OF TUMORS OF THE NASOPHARYNX AND LARYNX

被引:21
作者
LEEZENBERG, JA
WESSELING, H
KROON, AM
机构
[1] UNIV GRONINGEN, SCH MED, INST KLIN FARMACOL, NL-9713 BZ GRONINGEN, NETHERLANDS
[2] UNIV GRONINGEN, SCH MED, PHYSIOL CHEM LAB, NL-9713 BZ GRONINGEN, NETHERLANDS
[3] FREE UNIV AMSTERDAM HOSP, DEPT EAR NOSE & THROAT, AMSTERDAM, NETHERLANDS
关键词
cytostatic action; doxycycline; laryngeal carcinoma; methotrexate; nasopharyngeal carcinoma; oxytetracycline; prognosis; vibramycin;
D O I
10.1007/BF00608401
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
218 patients with a tumor of the larynx or nasopharynx, who had been treated with various forms of combination therapy, and who had died in the period 1964-1976, were studied retrospectively to see if addition of tetracyclines to the treatment had influenced survival time. The patients who received tetracycline appeared to have lived longer. Further, from analysis of all patients from 1-10 years after treatment, it appeared that addition of methotrexate to conventional therapy (surgery, radiation) had worsened the prognosis, in contrast to tetracycline. Tetracycline alone gave slightly better results than in the control group. It had also considerably improved survival in patients who had also received methotrexate. Inhibition of mitochondrial protein synthesis by the tetracyclines is proposed as possible mechanism of the effect. It is suggested that tetracyclines may also be valuable in the treatment of other types of cancer, especially because they appear to be nontoxic as far as bone-marrow function is concerned. © 1979 Springer-Verlag.
引用
收藏
页码:237 / 241
页数:5
相关论文
共 16 条
[1]  
DAVIS RC, 1977, CANCER RES, V37, P4539
[2]   TOXICITY OF TETRACYCLINES IN RAT-SMALL-INTESTINAL EPITHELIUM AND LIVER [J].
DEJONGE, HR .
BIOCHEMICAL PHARMACOLOGY, 1973, 22 (21) :2659-2677
[3]   ON EFFECT OF CHLORAMPHENICOL AND OXYTETRACYCLINE ON BIOGENESIS OF MAMMALIAN MITOCHONDRIA [J].
DEVRIES, H ;
KROON, AM .
BIOCHIMICA ET BIOPHYSICA ACTA, 1970, 204 (02) :531-&
[4]  
DOLL WRS, 1972, ADVERSE DRUG REACT, P70
[5]  
GIJZEL W P, 1972, Cell Differentiation, V1, P191, DOI 10.1016/0045-6039(72)90028-0
[6]  
GIJZEL WP, 1978, J MOL MED, V3, P157
[7]  
Kroon A M, 1970, Symp Soc Exp Biol, V24, P181
[8]  
KROON AM, 1976, ACTA CARDIOL, V31, P1
[9]  
KROON AM, 1972, MITOCHONDRIA BIOMEMB, V28, P71
[10]  
LEEZENBERG JA, 1976, NED TIJDSCHR GENEES, V120, P1770